SCHEMBL23611499

SCHEMBL23611499

CC(C)Oc1ccc(-c2ncc(CNc3cc(-n4cncn4)nc(C(F)(F)F)c3)cn2)cc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C19 P33261 2/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ S1PR1 P21453 6/20 0.43
▸ KCNH2 Q12809 1/20 0.35
▸ HDAC1 Q13547 1/20 0.34
▸ HDAC6 Q9UBN7 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ GLA P06280 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ GRM7 Q14831 1/20 0.34
▸ P2RX3 P56373 2/20 0.33
▸ MAP4K4 O95819 2/20 0.33
▸ MINK1 Q8N4C8 2/20 0.33
▸ PRKCD Q05655 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ PRMT6 Q96LA8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30060461 1.00 CYP2C19 (0.47) CYP2C19CYP2C9S1PR1KCNH2HDAC1
SCHEMBL23611365 0.88 SMN1; SMN2 (0.40) CYP2C19CYP2C9HDAC1HDAC6ALDH1A1
SCHEMBL23611440 0.88 CYP2C19 (0.47) CYP2C19CYP2C9S1PR1KCNH2HDAC1
SCHEMBL30062040 0.88 CYP2C19 (0.47) CYP2C19CYP2C9S1PR1KCNH2HDAC1
SCHEMBL30062470 0.86 CYP2C19 (0.49) CYP2C19CYP2C9S1PR1KCNH2ALDH1A1
SCHEMBL23611436 0.85 CYP2C19 (0.67) CYP2C19CYP2C9S1PR1KCNH2HDAC1
SCHEMBL30060476 0.85 CYP2C19 (0.67) CYP2C19CYP2C9S1PR1KCNH2HDAC1
SCHEMBL21611920 0.84 CYP2C19 (0.54) CYP2C19CYP2C9S1PR1KCNH2SMN1; SMN2
SCHEMBL23611431 0.82 VNN1 (0.38) HDAC1HDAC6ALDH1A1GLAHPGD
SCHEMBL30060453 0.82 VNN1 (0.38) HDAC1HDAC6ALDH1A1GLAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4085057-A1 NOVEL PQSR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2022-11-09 — — EP disclosed
WO-2021136805-A1 NOVEL PqsR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2021-07-08 — — WO disclosed
Send feedback